Literature DB >> 11526183

Prevalence of molecular types and mecA gene carriage of coagulase-negative Staphylococci in a neonatal intensive care unit: relation to nosocomial septicemia.

T G Krediet1, M E Jones, K Janssen, L J Gerards, A Fleer.   

Abstract

Molecular typing of isolates revealed that neonatal coagulase-negative staphylococcal (CONS) septicemia is most frequently caused by predominant, antibiotic-resistant CONS types, which are widely distributed among both neonates and staff of the neonatal unit, suggesting cross-contamination. Therefore, infection control measures may be valuable in the prevention of this common nosocomial septicemia.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11526183      PMCID： PMC88351          DOI： 10.1128/JCM.39.9.3376-3378.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

2.  Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR.

Authors:  F J Schmitz; C R Mackenzie; B Hofmann; J Verhoef; M Finken-Eigen; H P Heinz; K Köhrer
Journal:  J Med Microbiol       Date:  1997-09       Impact factor: 2.472

Review 3.  Antimicrobial susceptibility of coagulase-negative staphylococci.

Authors:  G L Archer; M W Climo
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

4.  An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients.

Authors:  D E Low; B K Schmidt; H M Kirpalani; R Moodie; B Kreiswirth; A Matlow; E L Ford-Jones
Journal:  Pediatrics       Date:  1992-04       Impact factor: 7.124

Review 5.  Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution.

Authors:  E Suzuki; K Hiramatsu; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors.

Authors:  C L Vermont; N G Hartwig; A Fleer; P de Man; H Verbrugh; J van den Anker; R de Groot; A van Belkum
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

9.  Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years.

Authors:  J Huebner; G B Pier; J N Maslow; E Muller; H Shiro; M Parent; A Kropec; R D Arbeit; D A Goldmann
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

10.  Randomly amplified polymorphic DNA analysis provides rapid differentiation of methicillin-resistant coagulase-negative staphylococcus bacteremia isolates in pediatric hospital.

Authors:  E Bingen; M C Barc; N Brahimi; E Vilmer; F Beaufils
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948
View more
  8 in total

Review 1.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

2.  Evaluation of Oxacillin and Cefoxitin Disk Diffusion and Microbroth Dilution Methods for Detecting mecA-Mediated β-Lactam Resistance in Contemporary Staphylococcus epidermidis Isolates.

Authors:  Samia N Naccache; Katrina Callan; C A Burnham; Meghan A Wallace; Lars F Westblade; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

3.  The role of breast milk in the colonization of neonatal gut and skin with coagulase-negative staphylococci.

Authors:  Hiie Soeorg; Tuuli Metsvaht; Imbi Eelmäe; Mirjam Merila; Sirli Treumuth; Kristi Huik; Marika Jürna-Ellam; Mari-Liis Ilmoja; Irja Lutsar
Journal:  Pediatr Res       Date:  2017-08-02       Impact factor: 3.756

Review 4.  Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship.

Authors:  Sameer J Patel; Lisa Saiman
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

5.  Molecular epidemiology of coagulase-negative staphylococci causing sepsis in a neonatal intensive care unit over an 11-year period.

Authors:  Tannette G Krediet; Ellen M Mascini; Ellen van Rooij; Judith Vlooswijk; Armand Paauw; Leo J Gerards; André Fleer
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Diversity of staphylococcal cassette chromosome mec elements in nosocomial multiresistant Staphylococcus haemolyticus isolates.

Authors:  Ewa Szczuka; Magdalena Krajewska; Dagmara Lijewska; Karolina Bosacka; Adam Kaznowski
Journal:  J Appl Genet       Date:  2016-04-07       Impact factor: 3.240

7.  Molecular epidemiology of coagulase-negative Staphylococcus carriage in neonates admitted to an intensive care unit in Brazil.

Authors:  Yves Mauro Ternes; Juliana Lamaro-Cardoso; Maria Cláudia Porfirio André; Vicente Porfírio Pessoa; Maria Aparecida da Silva Vieira; Ruth Minamisava; Ana Lúcia Andrade; André Kipnis
Journal:  BMC Infect Dis       Date:  2013-12-05       Impact factor: 3.090

8.  Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review.

Authors:  Jasmine Chong; Chelsea Caya; Simon Lévesque; Caroline Quach
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.